REGISTERED NUMBER: 16263894 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD

19 FEBRUARY 2025 TO 30 JUNE 2026

FOR

ANDESCO MEDICAL LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTORS:

Miss K Breen

Miss J L Jarvis

REGISTERED OFFICE:

45 Queen Street

Deal

CT14 6EY

REGISTERED NUMBER:

16263894 (England and Wales)

ACCOUNTANTS:

Higson & Co (Deal) Ltd

45 Queen Street

Deal

Kent

CT14 6EY

FIXED ASSETS

Tangible assets

4

273

CURRENT ASSETS

Debtors

5

122,850

Cash at bank and in hand

50,752

173,602

CREDITORS

Amounts falling due within one year

6

155,787

NET CURRENT ASSETS

17,815

TOTAL ASSETS LESS CURRENT LIABILITIES

18,088

CAPITAL AND RESERVES

Called up share capital

2

Retained earnings

18,086

18,088

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 June 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 June 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 October 2026 and were signed on its behalf by:

Miss K Breen - Director

Miss J L Jarvis - Director

1.	STATUTORY INFORMATION

Andesco Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on cost

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 .

4.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

Additions

297

At 30 June 2026

297

DEPRECIATION

Charge for period

24

At 30 June 2026

24

NET BOOK VALUE

At 30 June 2026

273

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Trade debtors

122,850

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

£

Trade creditors

86,148

Tax

5,897

VAT

39,990

Other creditors

22,328

Directors' current accounts

624

Accrued expenses

800

155,787

Other creditors represents:

An amount of £11,205 due to JLJ Consulting Ltd, a company controlled by one of the directors.

An amount of £11,123 due to KB Spine & Consulting Ltd, a company controlled by one of the directors.

Interest on both loans accrues at 8% per annum. Both loans are repayable on demand.

7.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 30 June 2026:

£

Miss K Breen

Balance outstanding at start of period

-

Amounts advanced

312

Amounts repaid

-

Amounts written off

-

Amounts waived

-

Balance outstanding at end of period

312

Miss J L Jarvis

Balance outstanding at start of period

-

Amounts advanced

312

Amounts repaid

-

Amounts written off

-

Amounts waived

-

Balance outstanding at end of period

312